Publication | Closed Access

Vascular Endothelial Growth Factor A c.*237C>T polymorphism is associated with bevacizumab efficacy and related hypertension in metastatic colorectal cancer

Bevacizumab EfficacyT PolymorphismMedicineImmunologyColorectal CancerPathologyVascular BiologyRelated HypertensionCancer GeneticsOncologyCancer GrowthCancer Research